[go: up one dir, main page]

DE60028022D1 - Herstellung von biologisch aktiven molekülen - Google Patents

Herstellung von biologisch aktiven molekülen

Info

Publication number
DE60028022D1
DE60028022D1 DE60028022T DE60028022T DE60028022D1 DE 60028022 D1 DE60028022 D1 DE 60028022D1 DE 60028022 T DE60028022 T DE 60028022T DE 60028022 T DE60028022 T DE 60028022T DE 60028022 D1 DE60028022 D1 DE 60028022D1
Authority
DE
Germany
Prior art keywords
preparation
biologically active
active molecules
molecules
biologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60028022T
Other languages
English (en)
Other versions
DE60028022T2 (de
Inventor
Menachem Rubinstein
Bianling Liu
Daniela Novick
Pierre Graber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Application granted granted Critical
Publication of DE60028022D1 publication Critical patent/DE60028022D1/de
Publication of DE60028022T2 publication Critical patent/DE60028022T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
DE60028022T 1999-04-13 2000-04-13 Herstellung von biologisch aktiven molekülen Expired - Lifetime DE60028022T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12942799 1999-04-13
IL12942799A IL129427A0 (en) 1999-04-13 1999-04-13 Preparation of biologically active molecules
PCT/IL2000/000220 WO2000061768A2 (en) 1999-04-13 2000-04-13 Preparation of biologically active molecules

Publications (2)

Publication Number Publication Date
DE60028022D1 true DE60028022D1 (de) 2006-06-22
DE60028022T2 DE60028022T2 (de) 2006-09-28

Family

ID=11072700

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60028022T Expired - Lifetime DE60028022T2 (de) 1999-04-13 2000-04-13 Herstellung von biologisch aktiven molekülen

Country Status (24)

Country Link
US (1) US7098002B1 (de)
EP (1) EP1169460B1 (de)
JP (1) JP4822587B2 (de)
KR (1) KR100682185B1 (de)
CN (1) CN1324140C (de)
AR (1) AR023468A1 (de)
AT (1) ATE326536T1 (de)
AU (1) AU781342B2 (de)
BR (1) BR0009782A (de)
CA (1) CA2368994C (de)
DE (1) DE60028022T2 (de)
DK (1) DK1169460T3 (de)
EA (1) EA006825B1 (de)
EE (1) EE05591B1 (de)
ES (1) ES2259287T3 (de)
HK (1) HK1044351A1 (de)
IL (3) IL129427A0 (de)
MX (1) MXPA01010487A (de)
NO (1) NO329525B1 (de)
PT (1) PT1169460E (de)
SI (1) SI1169460T1 (de)
UA (1) UA73940C2 (de)
WO (1) WO2000061768A2 (de)
ZA (1) ZA200108364B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1336701A (en) * 1999-10-20 2001-04-30 Scios Inc. Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage
US7273722B2 (en) * 2000-11-29 2007-09-25 Allergan, Inc. Neurotoxins with enhanced target specificity
US7524488B2 (en) 2001-03-08 2009-04-28 Ares Trading S.A. Interleukin-18 mutants
IL142246A0 (en) * 2001-03-26 2002-03-10 Applied Research Systems Method and kit for quantitation of polypeptides
JP2005523001A (ja) 2002-02-11 2005-08-04 ザイモジェネティクス，インコーポレイティド 二量体増殖因子を調製するための材料と方法
NZ541551A (en) * 2003-02-21 2007-02-23 Biotecnol Sa Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions
AU2004265613B2 (en) * 2003-08-06 2010-12-09 University Of Maryland, College Park Engineered proteases for affinity purification and processing of fusion proteins
EP1689877A1 (de) * 2003-11-24 2006-08-16 Novo Nordisk A/S Fusionsproteine und verfahren zur spaltung solcher proteine
US7381794B2 (en) 2004-03-08 2008-06-03 Zymogenetics, Inc. Dimeric fusion proteins and materials and methods for producing them
ATE463506T1 (de) * 2005-09-19 2010-04-15 Allergan Inc Mit clostriedientoxin aktivierbare clostridientoxine
CA2649800C (en) 2006-04-20 2016-09-20 Kringle Pharma Inc. Hgf precursor protein variant and active protein thereof
DE102007008596B4 (de) * 2007-02-15 2010-09-02 Friedrich-Schiller-Universität Jena Biologisch wirksame Moleküle auf Grundlage von PNA und siRNA, Verfahren zu deren zellspezifischen Aktivierung sowie Applikationskit zur Verabreichung
EP2190861A4 (de) 2007-08-22 2011-03-30 Univ California Aktivierbare bindende polypeptide und verfahren zu deren identifikation und anwendung
KR100980315B1 (ko) * 2007-10-01 2010-09-07 한국생명공학연구원 대장균시스템을 이용한 인위적 활성화가 가능한 카스파제전구체 대량생산 및 활성화 방법
DE102009043743B4 (de) 2009-03-13 2016-10-13 Friedrich-Schiller-Universität Jena Zellspezifisch wirksame Moleküle auf Grundlage von siRNA sowie Applikationskits zu deren Herstellung und Verwendung
EP2385955B1 (de) 2009-01-12 2020-08-12 CytomX Therapeutics, Inc. Modifizierte antikörperzusammensetzungen, verfahren zu ihrer herstellung und verwendung
JP5861223B2 (ja) * 2009-02-23 2016-02-16 サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. プロタンパク質およびその使用方法
CN103923897B (zh) * 2013-01-11 2016-06-01 中国人民解放军军事医学科学院生物工程研究所 caspase重组酶原及其编码基因与应用
CN103388001B (zh) * 2013-07-16 2016-01-20 中国人民解放军第四军医大学 一种含凝血酶切割位点gst膜型表达载体及转染阳性细胞的方法
KR20160098277A (ko) 2013-12-20 2016-08-18 에프. 호프만-라 로슈 아게 개선된 재조합 폴리펩티드 제조 방법
MX392776B (es) 2015-03-30 2025-03-11 Greenlight Biosciences Inc Produccion de acido ribonucleico libre de celulas.
EP3313879B1 (de) 2015-06-24 2022-01-05 F. Hoffmann-La Roche AG Anti-transferrinrezeptorantikörper mit angepasster affinität
AR106189A1 (es) 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
AU2016333512B2 (en) 2015-10-02 2022-11-17 F. Hoffmann-La Roche Ag Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
RU2018138975A (ru) 2016-04-06 2020-05-12 Гринлайт Байосайенсис, Инк. Бесклеточная продукция рибонуклеиновой кислоты
AU2018347405B2 (en) 2017-10-11 2022-02-03 Greenlight Biosciences, Inc. Methods and compositions for nucleoside triphosphate and ribonucleic acid production
KR20200080749A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 N-말단의 메티오닌이 절단된 목적 단백질 발현용 유전자 발현 카세트 및 이를 이용하여 n-말단의 메티오닌이 절단된 목적 단백질을 생산하는 방법
CA3150818A1 (en) * 2019-08-13 2021-02-18 King's College London Immunoresponsive cells armoured with spatiotemporally restricted activity of cytokines of the il-1 superfamily

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824297A (en) * 1990-06-25 1998-10-20 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
WO1992000318A1 (en) * 1990-06-25 1992-01-09 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof
EP0533350B1 (de) * 1991-08-16 1999-05-26 Merck & Co. Inc. DNS, welche das Interleukin-1B-Vorläufer-Converting-Enzym kodiert
AU683834B2 (en) * 1991-12-31 1997-11-27 Zymogenetics Inc. Methods for producing thrombin
JPH06125784A (ja) * 1992-01-17 1994-05-10 Takeda Chem Ind Ltd モノクローナル抗体，ハイブリドーマ，その製造法および用途
US6303369B1 (en) * 1993-09-30 2001-10-16 Carl Spana Protein expression system
WO1997024441A1 (en) 1995-12-29 1997-07-10 Incyte Pharmaceuticals, Inc. Nucleic acids encoding interferon gamma inducing factor-2
JP4059941B2 (ja) * 1996-08-26 2008-03-12 社団法人芝蘭会 Ｒｈｏ標的タンパク質ｐ１４０ｍＤｉａ
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
JPH10327872A (ja) * 1997-05-30 1998-12-15 Otsuka Pharmaceut Co Ltd Ｂｃｌ−２相互作用蛋白遺伝子ｂｉｓ
CA2295957C (en) * 1997-08-07 2009-09-22 Toray Industries, Inc. Canine interleukin 18, canine interleukin 1.beta. converting enzyme, dna sequences encoding these, interleukin 18 production method and canine immune disease remedy

Also Published As

Publication number Publication date
EP1169460A2 (de) 2002-01-09
EP1169460B1 (de) 2006-05-17
EE05591B1 (et) 2012-10-15
IL129427A0 (en) 2000-02-17
EA006825B1 (ru) 2006-04-28
DE60028022T2 (de) 2006-09-28
UA73940C2 (uk) 2005-10-17
WO2000061768A3 (en) 2001-02-08
US7098002B1 (en) 2006-08-29
IL145842A0 (en) 2002-07-25
IL145842A (en) 2008-06-05
WO2000061768A2 (en) 2000-10-19
DK1169460T3 (da) 2006-09-18
AU3985100A (en) 2000-11-14
AU781342B2 (en) 2005-05-19
HK1044351A1 (en) 2002-10-18
SI1169460T1 (sl) 2006-08-31
KR100682185B1 (ko) 2007-02-12
NO20014966D0 (no) 2001-10-12
AR023468A1 (es) 2002-09-04
BR0009782A (pt) 2002-01-08
JP2002541813A (ja) 2002-12-10
KR20020007365A (ko) 2002-01-26
EE200100530A (et) 2002-12-16
ZA200108364B (en) 2002-10-11
JP4822587B2 (ja) 2011-11-24
CN1324140C (zh) 2007-07-04
CN1353761A (zh) 2002-06-12
EA200101078A1 (ru) 2002-04-25
CA2368994C (en) 2010-03-09
ES2259287T3 (es) 2006-10-01
CA2368994A1 (en) 2000-10-19
NO329525B1 (no) 2010-11-01
ATE326536T1 (de) 2006-06-15
PT1169460E (pt) 2006-07-31
MXPA01010487A (es) 2002-05-06
NO20014966L (no) 2001-12-11

Similar Documents

Publication Publication Date Title
DE60028022D1 (de) Herstellung von biologisch aktiven molekülen
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
DE60018429D1 (de) Herstellung von poly(trimethylenterephthalat)
DE60002918D1 (de) Herstellung von betonbeschleuniger
DE60019960D1 (de) Herstellung von isobutencopolymere
DE60013021D1 (de) Herstellung von S,S und R,S Aminosäuren-Isosteren
DE69934889D1 (de) Herstellung und reinigung von diboranen
DE59806485D1 (de) Herstellung von Ascorbylmonophosphaten
DE59915061D1 (de) Herstellung von strukturierten elektroden
DE60038118D1 (de) Formulierungen von wachstumshormonen
DE69801392D1 (de) Herstellung von Methylchlorid
DE59912915D1 (de) Herstellung von 4,4'-Diketo-carotinoiden
DE60142051D1 (de) Herstellung von perfluorolefinen
DE60132362D1 (de) Herstellung von ultradünnwandigen cordierit-strukturen
DE60028816D1 (de) Herstellung von unipolaren Komponenten
NO20016147D0 (no) Biologiske aktive materialer
DE69913556D1 (de) Herstellung von aminen
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
DE69935165D1 (de) Herstellung von polyolefin
ATE254929T1 (de) Oralverabreichbare lösung von prucaloprid
DE60016608D1 (de) Herstellung von sulfonylimin-verbindungen
ATE227733T1 (de) Herstellung von avermectin-verbindungen
DE60007111D1 (de) Herstellung von ausgewählten fluorolefinen
DE59804303D1 (de) Herstellung von Polyenaldehyden
DE69733607D1 (de) Herstellung von cycloalkyldiarylphosphinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition